If you are struggling with appetite control and are willing to take drastic measures to curb your hunger, then a small electronic implant is a possible solution. VBLOC Therapy was developed by EnteroMedics and UK-based MRC Clinical Sciences Center. The miniature device measures just a few milimeters wide but could have a big impact for those suffering from obesity.
Designed to regulate the chemical and electrical processes related to appetite control, the pacemaker-like device would be implanted in the peritoneal cavity's vagus nerve using electrodes. According to Industry Tap, the implant collects data, scores and spot-checks to determine whether or not the patient should be eating. Then, it sends signals to the brain to regulate how quickly one should eat. The invention bypasses qualities like self-control and fasting.
Key Themes Behind This Trend
- VBLOC Therapy
- EnteroMedics' VBLOC Therapy using electronic surgical implants to curb hunger presents opportunities for disruptive innovation in the medical industry.
- Electronic Implants for Appetite Control
- The innovation of using electronic implants to regulate appetite control presents potential for disruptive breakthroughs in the healthcare industry.
- Neuroscience-based Weight Management
- The use of neuroscience and technology to develop alternative methods for weight management presents opportunities for disruptive innovation in the healthcare space.
Where This Applies
- Medical Devices
- The development of VBLOC Therapy by EnteroMedics and MRC Clinical Sciences Center presents an opportunity for disruptive innovation in the medical device industry.
- Healthcare
- The use of electronic implants and neuroscience to address obesity presents opportunities for disruptive innovation in the healthcare industry.
- Weight Management
- Innovation in weight management through the use of technology and neuroscience presents opportunities for disruptive breakthroughs in the weight management industry.
